Association of tumor TROP2 expression with prognosis varies among lung cancer subtypes

TROP2 is a transmembrane glycoprotein that is overexpressed in various cancers. Emerging evidence suggests that TROP2-targeting therapies are efficacious and safe in patients with multiple prior treatments. TROP2 is a promising target for lung cancer treatment; however, little is known regarding the...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Inamura, Kentaro, Yokouchi, Yusuke, Kobayashi, Maki, Ninomiya, Hironori, Sakakibara, Rie, Subat, Sophia, Nagano, Hiroko, Nomura, Kimie, Okumura, Sakae, Shibutani, Tomoko, Ishikawa, Yuichi
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2017
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5438686/
https://ncbi.nlm.nih.gov/pubmed/28404926
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15647
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items